Estrogen receptor α and aromatase polymorphisms affect risk, prognosis, and therapeutic outcome in men with castration-resistant prostate cancer treated with docetaxel-based therapy

Tristan M. Sissung, Romano Danesi, C. Tyler Kirkland, Caitlin E. Baum, Sandra B. Ockers, Erica V. Stein, David Venzon, Douglas K. Price, William D. Figg

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Fingerprint

Dive into the research topics of 'Estrogen receptor α and aromatase polymorphisms affect risk, prognosis, and therapeutic outcome in men with castration-resistant prostate cancer treated with docetaxel-based therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry